Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Angion Announces Results from the Phase 2 ALI-201 Study in Patients with COVID-19 Associated Pneumonia

firstwordpharmaJune 30, 2021

Tag: Angion , ALI-201 , COVID-19

PharmaSources Customer Service